MetalloBio’s Executive Chairman and CEO has been appointed as Chair of the Board of antibiotics research company, Glox Therapeutics. Glox shall be utilising his depth of industry experience with the aim to accelerate their growth and provide guidance in the commercialisation of their technologies. His appointment was announced on the 11th of February. To learn more about his position and qualifications read the full article below.

‍Glox Therapeutics Strengthens Team Appointing Dr Michael Murray as Chair and Dr Nel Moore as Scientific Advisory Board Member